Elsevier Launches Nationwide ClinicalKey Experience Tour

Cross-country tour showcases the latest innovations in clinical reference tools

Philadelphia, October 2, 2012 – Elsevier, a world-leading provider of scientific, technical and medical information products and services, has launched a nationwide “ClinicalKey Experience Tour” to promote the importance of a reliable and fast clinical reference tool that provides better answers to physicians’ clinical questions and thus improves patient care.

The “ClinicalKey Experience” tour is an all-day outdoor event showcasing and promoting live demonstrations of ClinicalKey. The tour will visit hospitals and academic medical centers across the country and features a customized, walk-in demonstration pod set up adjacent to hospitals and open to clinicians and hospital staff. Attendees are invited to stop by the tour at any time throughout the scheduled day for a short demo and trial of ClinicalKey, as well as refreshments. The events take place from approximately 7:30 a.m. to 4:30 p.m.

The customized “ClinicalKey Experience” pod is a 20-foot transportable suite that unfolds to include about 470 square feet of open air space, atmospheric lighting, fans, phone chargers, Wi-Fi, and comfortable seating. It includes interactive demo stations for physicians to test drive the product firsthand, plus giveaway items.

“Physicians are starved for time, overwhelmed with data, and have just minutes to make decisions that are critical to patient care. A global reference tool that accurately discovers valuable medical information, missed by other search engines is needed to better patient care,” said Jim Donohue, Managing Director for Global Clinical Reference, Elsevier. “This tour gives physicians, librarians and hospital administrators across the country a hands-on opportunity to see and try out ClinicalKey’s cutting-edge technology.”

Launched in April 2012, ClinicalKey provides the most current clinically relevant evidence-based answers, as well as expert commentary, MEDLINE abstracts and select third-party journals. ClinicalKey is powered by Elsevier's Smart Content, tagged with EMMeT (Elsevier Merged Medical Taxonomy), which enables ClinicalKey to understand clinical terms and thus discover medical content that is the most relevant, plus find related content that would be missed by other search engines. Elsevier's Smart Content has been designed to understand the vast number of relationships between clinical concepts. By organizing these relationships in a hierarchical manner, it guarantees that ClinicalKey provides specific, targeted results to physicians' questions.

The tour launched in St. Louis, Mo., on Sept. 18 and will travel to major cities in Wisconsin, Minnesota, Illinois, Kentucky, Indiana, Ohio, Massachusetts, New York, Pennsylvania, Maryland, District of Columbia, Virginia, South Carolina, Florida, Louisiana, Texas and Colorado. The last day of the tour will be Dec. 12.

For more information about the ClinicalKey Experience Tour dates and locations, visit http://info.clinicalkey.com/experience/. For more information on ClinicalKey please visit www.clinicalkey.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence,and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 33,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
+1 212 633 3164